Atlas Trials

Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors

Clinical trial NCT00004095 · COMPLETED

Trial details

NCT number
NCT00004095
Sponsor
Northwestern University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Bladder CancerBreast CancerColorectal CancerKidney CancerLung CancerPancreatic Cancer
Start date
1999-08-01
Primary completion
2008-10-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.